Rep. Jonathan L. Jackson Sells Tenet Healthcare Corporation (NYSE:THC) Shares

Representative Jonathan L. Jackson (Democratic-Illinois) recently sold shares of Tenet Healthcare Corporation (NYSE:THC). In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Tenet Healthcare stock on February 11th. The trade occurred in the Representative’s “MORGAN STANLEY – ROLLOVER IRA” account.

Representative Jonathan L. Jackson also recently made the following trade(s):

• Purchased $50,001 – $100,000 in shares of Bank of New York Mellon (NYSE:BK) on 2/17/2026.
• Sold $1,001 – $15,000 in shares of International Business Machines (NYSE:IBM) on 2/17/2026.
• Purchased $1,001 – $15,000 in shares of Bank of New York Mellon (NYSE:BK) on 2/17/2026.
• Sold $50,001 – $100,000 in shares of International Business Machines (NYSE:IBM) on 2/17/2026.
• Sold $1,001 – $15,000 in shares of Amazon.com (NASDAQ:AMZN) on 2/11/2026.
• Purchased $1,001 – $15,000 in shares of Welltower (NYSE:WELL) on 2/11/2026.
• Purchased $1,001 – $15,000 in shares of Citigroup (NYSE:C) on 2/11/2026.
• Sold $50,001 – $100,000 in shares of Palo Alto Networks (NASDAQ:PANW) on 2/5/2026.
• Purchased $1,001 – $15,000 in shares of Amazon.com (NASDAQ:AMZN) on 2/5/2026.
• Purchased $50,001 – $100,000 in shares of Citigroup (NYSE:C) on 2/5/2026.

Tenet Healthcare Stock Down 1.8%

Shares of Tenet Healthcare stock opened at $199.74 on Wednesday. The company’s fifty day simple moving average is $213.92 and its two-hundred day simple moving average is $205.23. Tenet Healthcare Corporation has a 12-month low of $109.82 and a 12-month high of $247.21. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. The company has a market cap of $17.37 billion, a P/E ratio of 12.89, a PEG ratio of 0.98 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. During the same quarter in the previous year, the firm posted $3.44 EPS. The company’s revenue for the quarter was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Research analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Hedge Funds Weigh In On Tenet Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the stock. NewEdge Advisors LLC increased its stake in Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after purchasing an additional 166 shares in the last quarter. Jones Financial Companies Lllp grew its holdings in shares of Tenet Healthcare by 299.1% during the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after buying an additional 1,274 shares during the last quarter. Sivia Capital Partners LLC bought a new stake in shares of Tenet Healthcare during the second quarter valued at approximately $290,000. AE Wealth Management LLC raised its holdings in Tenet Healthcare by 28.2% in the 2nd quarter. AE Wealth Management LLC now owns 7,133 shares of the company’s stock worth $1,255,000 after acquiring an additional 1,569 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in Tenet Healthcare by 52.7% during the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 336 shares of the company’s stock valued at $59,000 after purchasing an additional 116 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors.

Insider Transactions at Tenet Healthcare

In other news, EVP Thomas W. Arnst sold 24,000 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the transaction, the executive vice president directly owned 8,012 shares of the company’s stock, valued at $1,875,128.48. This represents a 74.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Paola M. Arbour sold 6,500 shares of Tenet Healthcare stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the sale, the executive vice president owned 29,291 shares of the company’s stock, valued at $6,983,853.13. The trade was a 18.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 46,517 shares of company stock worth $10,943,111 over the last quarter. 0.81% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Weiss Ratings upgraded Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Truist Financial raised their price objective on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Morgan Stanley restated an “overweight” rating and set a $260.00 target price on shares of Tenet Healthcare in a report on Thursday, February 12th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Sunday, March 1st. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $250.56.

About Representative Jackson

Jonathan Jackson (Democratic Party) is a member of the U.S. House, representing Illinois’ 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Jackson (Democratic Party) is running for re-election to the U.S. House to represent Illinois’ 1st Congressional District. He declared candidacy for the 2026 election.

Jonathan Jackson was born in Chicago, Illinois. Jackson graduated from Whitney Young High School. He earned an M.B.A. from Northwestern University. Jackson’s career experience includes working as an investment analyst and an entrepreneur.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.